Article Details

FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab)

Retrieved on: 2021-07-30 17:37:30

Tags for this article:

Click the tags to see associated articles and topics

FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab). View article details on hiswai:

Excerpt

Circulating SARS-CoV-2 viral variants may be associated with resistance to monoclonal antibodies. Healthcare providers should review the Antiviral ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up